REVIEW article
Front. Microbiol.
Sec. Microorganisms in Vertebrate Digestive Systems
Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1672780
This article is part of the Research TopicNew and advanced mechanistic insights into the influences of the infant gut microbiota on human health and disease, Volume IIView all 7 articles
Microbial Beginnings: Determinants and Disruptions of the Neonatal Microbiome
Provisionally accepted
- Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The perinatal period is a critical window in human development, during which the neonatal microbiome, shaped by maternal, environmental, and clinical factors, influences immune, metabolic, and neurodevelopmental processes. Early-life microbial assembly is an active, multisite, and functionally significant phenomenon, modulated by delivery mode, feeding practices, maternal microbiota, and antibiotic exposure. Vertical microbial transmission from the maternal gut, vagina, skin, and breast milk contributes to the colonization of the infant with taxa such as Bifidobacterium and Lactobacillus, while disruptions associated with cesarean section, formula feeding, or antibiotic use have been linked to persistent dysbiosis, impaired immune maturation, and increased risk of inflammatory, metabolic, and neurodevelopmental conditions. Recent studies also challenge the sterile womb paradigm, suggesting that prenatal microbial signals, whether microbes or metabolites, may reach the maternal–fetal interface and affect fetal programming. Furthermore, neonatal microbial profiles have been associated with later-life health trajectories, suggesting exploratory value as research biomarkers; however, these associations remain preliminary and are not validated for clinical application. In this review, we summarize and integrate evidence from multiomic, clinical, and experimental studies to describe the determinants, developmental dynamics, and health consequences of the neonatal microbiome. We also highlight emerging microbiome-targeted approaches, including maternal and neonatal probiotics, nutritional modulation, and systems biology frameworks, that may help to optimize early development and reduce disease risk. Understanding and modulating the perinatal microbiome represents a promising avenue for precision medicine and early-life prevention strategies.
Keywords: perinatal microbiome, Immune development, Vertical transmission, Dysbiosis, precision medicine
Received: 24 Jul 2025; Accepted: 23 Sep 2025.
Copyright: © 2025 Bautista and López-Cortés. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Andrés López-Cortés, aalc84@gmail.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.